Rigel Pharmaceuticals, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

FAIR VALUE (Tables)

FAIR VALUE (Tables)

12 Months Ended

Dec. 31, 2016

Schedule of financial assets measured at fair value on a recurring basis

Financial assets measured at fair value on a recurring basis are categorized in the tables below based upon the lowest level of significant input to the valuations (in thousands):


	Assets at Fair Value as of December 31, 2016
	Level 1		Level 2		Level 3		Total
Money market funds	$	9,496	$	—	$	—	$	9,496
U. S. treasury bills		—		4,300		—		4,300
Government-sponsored enterprise securities		—		16,459		—		16,459
Corporate bonds and commercial paper		—		44,271		—		44,271
Total	$	9,496	$	65,030	$	—	$	74,526


	Assets at Fair Value as of December 31, 2015
	Level 1		Level 2		Level 3		Total
Money market funds	$	26,291	$	—	$	—	$	26,291
U. S. treasury bills		—		9,048		—		9,048
Government-sponsored enterprise securities		—		48,613		—		48,613
Corporate bonds and commercial paper		—		40,206		—		40,206
Total	$	26,291	$	97,867	$	—	$	124,158